Lv6
2360 积分 2024-11-20 加入
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
1个月前
已完结
Enhanced Penetration and Retention of an Antibody in the Articular Cartilage Through Aggrecan Binding and Molecular Downsizing
4个月前
已完结
Engineering scFv immunotherapies: From CAR T cells to bispecific antibodies
7个月前
已完结
Domain Interactions in the Fab Fragment: A Comparative Evaluation of the Single-chain Fv and Fab Format Engineered with Variable Domains of Different Stability
7个月前
已完结
Folding-mediated secretion of pure bispecific antibodies
10个月前
已完结
PD-1–targeted cis-delivery of an IL-2 variant induces a multifaceted antitumoral T cell response in human lung cancer
11个月前
已完结
New insights into antibody structure with implications for specificity, variable region restriction and isotype choice
11个月前
已完结
Engineering IL-2 for immunotherapy of autoimmunity and cancer
1年前
已完结
Biology and regulation of IL-2: from molecular mechanisms to human therapy
1年前
已完结
Interleukin 2 (IL-2) variants engineered for increased IL-2 receptor alpha-subunit affinity exhibit increased potency arising from a cell surface ligand reservoir effect
1年前
已关闭
皖公网安备34019202002308
